BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1227 related articles for article (PubMed ID: 6234352)

  • 1. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of the presentation of minor lymphocyte stimulating determinants. I. Combined importance of MHC and non-MHC influences.
    Ryan JJ; Mond JJ; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1063-73. PubMed ID: 3135319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition and response to alloantigens in vivo. II. Priming with accessory cell-depleted donor allogeneic splenocytes: induction of specific unresponsiveness to foreign major histocompatibility complex determinants.
    Ryan JJ; Gress RE; Hathcock KS; Hodes RJ
    J Immunol; 1984 Nov; 133(5):2343-50. PubMed ID: 6207227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mlsd-defined primary mixed lymphocyte reaction: a composite response to Mlsa and Mlsc determinants.
    Ryan JJ; Mond JJ; Finkelman FD
    J Immunol; 1987 Jun; 138(12):4085-92. PubMed ID: 2438333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of the presentation of minor lymphocyte-stimulating determinants. II. Differing non-MHC control of super-stimulatory and more poorly stimulatory Mls phenotypes.
    Ryan JJ; LeJeune HB; Mond JJ; Finkelman FD
    J Immunol; 1990 Apr; 144(7):2506-17. PubMed ID: 2138649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation requirements of cloned inducer T cells. III. Need for two stimulator cells in the response of a cloned line to Mls determinants.
    DeKruyff RH; Ju ST; Laning J; Cantor H; Dorf ME
    J Immunol; 1986 Aug; 137(4):1109-14. PubMed ID: 2426352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-2K/H-2D and Mls and I region-associated antigens stimulate helper factor(s) involved in the generation of cytotoxic T lymphocytes.
    Scott JW; Ponzio NM; Orosz CG; Finke JH
    J Immunol; 1980 May; 124(5):2378-83. PubMed ID: 6444971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble suppressor of T cell proliferation in primary in vitro response to murine minor histocompatibility antigens.
    Solana R; Alonso MC; de la Fuente M; Alonso A; Peña J
    Rev Esp Fisiol; 1984 Sep; 40(3):341-52. PubMed ID: 6240742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell responses to Mls determinants are restricted by cross-reactive MHC determinants.
    Lynch DH; Gress RE; Needleman BW; Rosenberg SA; Hodes RJ
    J Immunol; 1985 Apr; 134(4):2071-8. PubMed ID: 2579127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECIFIC positive and negative selection of rat lymphocytes reactive to strong histocompatibility antigens: activation with alloantigens in vitro and in vivo.
    Wilson DB; Marshak A; Howard JC
    J Immunol; 1976 Apr; 116(4):1030-40. PubMed ID: 56402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell lines with dual specificity for strong Mls and H-2 determinants.
    Molnar-Kimber KL; Webb SR; Sprent J; Wilson DB
    J Immunol; 1980 Dec; 125(6):2643-5. PubMed ID: 6159415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo priming of mouse CTL precursors directed to product of a newly defined minor H-42 locus is under a novel control of class II MHC gene.
    Ishikawa H; Suzuki H; Hino T; Kubota E; Saito K
    J Immunol; 1985 Dec; 135(6):3681-5. PubMed ID: 3934264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GVHR elicited by products of class I or class II loci of the MHC: analysis of the response of mouse T lymphocytes to products of class I and class II loci of the MHC in correlation with GVHR-induced mortality, medullary aplasia, and enteropathy.
    Piguet PF
    J Immunol; 1985 Sep; 135(3):1637-43. PubMed ID: 2410497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunobiology of the T cell response to Mls-locus-disparate stimulator cells. I. Unidirectionality, new strain combinations, and the role of Ia antigens.
    Janeway CA; Katz ME
    J Immunol; 1985 Apr; 134(4):2057-63. PubMed ID: 2579125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids.
    Krzystyniak K; Panaye G; Descotes J; Revillard JP
    Immunopharmacol Immunotoxicol; 1992; 14(4):865-82. PubMed ID: 1363474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.